Tag: COFEPRIS
Zydus Lifesciences secures COFEPRIS approval to market MamitraTM in Mexico for...
With the approval of MamitraTM, Zydus aims to provide affordable cancer treatments for HER2-positive breast and gastric cancer patients
Zydus secures Mexico’s COFEPRIS approval for its biosimilar ‘Bhava’ to treat...
Zydus Lifesciences receives approval to market Bhava™ for various cancers in Mexico, expanding access to affordable oncology treatments